FDA Approved: RELISTOR — Supplemental Application (Salix Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Relistor (methylnaltrexone bromide) from Salix Pharmaceuticals to update its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-induced Constipation

Drugs mentioned

• RELISTOR (methylnaltrexone)

Snippet

SUPPL AP for RELISTOR (METHYLNALTREXONE BROMIDE)